We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Edwards Lifesciences Halts Heart Valve Trial in Wake of Patient Complications
Edwards Lifesciences Halts Heart Valve Trial in Wake of Patient Complications
June 17, 2005
Edwards Lifesciences has voluntarily delayed patient enrollment in its U.S. percutaneous aortic heart valve feasibility trial after serious complications with participants leading to the death of at least one patient.